Germany’s Election Results and their impact on the Cannabis Market

The 2025 German federal elections have reshaped the country’s political landscape, with the conservative CDU/CSU alliance, led by Friedrich Merz, emerging victorious with 28.5% of the vote. Meanwhile, the far-right Alternative for Germany (AfD) secured its best result yet at 20.8%, while the ruling Social Democratic Party (SPD) suffered a setback, receiving only 16.4%.

This outcome signals a shift towards more conservative policies, which could have significant implications for cannabis regulation—particularly in the recreational sector.

How the Election Could Impact Cannabis Policy

According to Sita Schubert, General Secretary of the EuMCA and CTA Board Member, the effects on cannabis will likely be targeted rather than sweeping:

• Medicinal Cannabis Is Secure – The medical sector is protected by existing legislation, G-BA rulings, and a stable regulatory framework. No major disruptions are expected.
• Recreational Use May Face Restrictions – Home cultivation and cannabis clubs could see new limitations or even rollbacks under a more conservative government.
• Scientific Pilot Studies Could Continue – Despite the shift in power, scientific trials on recreational cannabis are expected to remain in place, as the SPD is unlikely to support a full reversal.

A More Restrictive Approach to Recreational Cannabis?

Germany’s partial legalisation of cannabis in April 2024 allowed adults to grow up to three plants and possess up to 50 grams at home. While these policies were a step forward, they have faced strong opposition from the CDU/CSU and medical associations, which have raised concerns about public health and youth exposure.

With a CDU/CSU-SPD coalition likely, the new government may tighten regulations on personal use while allowing ongoing scientific research. However, a full repeal of existing laws appears unlikely given the SPD’s continued support for controlled reform.

What’s Next?

Germany’s cannabis industry now faces a period of uncertainty, especially for those in the personal use and social club sectors. However, medicinal cannabis businesses remain protected, and the scientific research framework may still provide opportunities for expansion.

As the new government takes shape, industry stakeholders will need to monitor policy developments closely to navigate the evolving regulatory environment. While medicinal cannabis remains secure, the future of recreational use now depends on how far the CDU/CSU pushes for new restrictions.